Wells Fargo’s Jaguar Health JAGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$15 Sell
5
-1
-17% -$6 ﹤0.01% 6999
2026
Q1
$74 Buy
+6
New +$131 ﹤0.01% 6539
2024
Q2
Hold
0
-$34 7181
2024
Q1
Hold
0
6947
2023
Q4
Hold
0
7250
2023
Q3
Hold
0
7066
2023
Q2
Hold
0
7043
2023
Q1
Hold
0
7538
2022
Q4
Hold
0
6932
2022
Q3
Hold
0
7004
2022
Q2
Hold
0
7148
2022
Q1
Hold
0
7436
2021
Q4
Hold
0
7515
2021
Q3
Hold
0
6727
2021
Q2
Hold
0
6680
2021
Q1
Hold
0
6732
2020
Q4
Hold
0
6741
2020
Q3
Hold
0
6607
2020
Q2
Hold
0
6549
2020
Q1
Hold
0
6495

Other funds holding JAGX

Wells Fargo's JAGX Position: Q2 2026 in Review

Wells Fargo reduced its Jaguar Health (JAGX) stake by 17% in Q2 2026, selling an estimated $6 and leaving 5 shares worth $15. The position accounts for ﹤0.01% of the portfolio, ranked #6999.

Wells Fargo first reported a position in JAGX in Q1 2026 and has held it in 2 quarters since. The position peaked at $74 in Q1 2026. 8 funds tracked by Wall St. Rank hold JAGX as of Q2 2026.

  • Wells Fargo held 5 shares of Jaguar Health worth $15 as of Q2 2026.
  • Wells Fargo sold 1 Jaguar Health share in Q2 2026, an estimated $6.
  • Jaguar Health made up ﹤0.01% of Wells Fargo's portfolio in Q2 2026, its #6999 holding.
  • Wells Fargo first reported a position in Jaguar Health in Q1 2026 and has held it in 2 quarters since.
  • Wells Fargo's Jaguar Health position peaked at $74 in Q1 2026.
  • 8 funds tracked by Wall St. Rank held Jaguar Health as of Q2 2026.

Based on Wells Fargo's 13F filing for Q2 2026, filed 14 Aug 2026.